The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
    1. About this group
    2. Reviews
      1. Active placebos versus antidepressants for depressionReview
      2. Acupuncture for depressionReview
      3. Acupuncture for insomniaReview
      4. Alprazolam for depressionReview
      5. Amitriptyline for depressionReview
      6. Amitriptyline versus placebo for major depressive disorderReview
      7. Antidepressant prevention of postnatal depressionReview
      8. Antidepressant treatment for post-natal depressionReview
      9. Antidepressants for anorexia nervosaReview
      10. Antidepressants for depressed elderlyReview
      11. Antidepressants for depression in medical illnessReviewWithdrawn
      12. Antidepressants for depression in physically ill peopleReview
      13. Antidepressants for generalized anxiety disorderReview
      14. Antidepressants plus benzodiazepines for major depressionReview
      15. Antidepressants versus placebo for depression in primary careReview
      16. Antidepressants versus placebo for people with bulimia nervosaReview
      17. Antidepressants versus placebo for the depressed elderlyReview
      18. Antidepressants versus psychological treatments and their combination for bulimia nervosaReview
      19. Antiglucocorticoid treatments for mood disordersReview
      20. Azapirones for generalized anxiety disorderReview
      21. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescentsReview
      22. Citalopram versus other anti-depressive agents for depressionReview
      23. Cognitive behaviour therapy for chronic fatigue syndrome in adultsReview
      24. Cognitive behavioural therapy for anxiety disorders in children and adolescentsReview
      25. Collaborative care for depression and anxiety problemsReview
      26. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)Review
      27. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobiaReview
      28. Combined psychotherapy plus benzodiazepines for panic disorderReview
      29. Consultation letters for medically unexplained physical symptoms in primary careReview
      30. Continuation and maintenance treatments for depression in older peopleReview
      31. Counselling for mental health and psychosocial problems in primary careReview
      32. Drugs versus placebo for dysthymiaReview
      33. Duloxetine versus other anti-depressive agents for depressionReview
      34. Early psychological interventions to treat acute traumatic stress symptomsReview
      35. Electroconvulsive therapy for the depressed elderlyReview
      36. Escitalopram versus other antidepressive agents for depressionReview
      37. Exercise for depressionReview
      38. Exercise in prevention and treatment of anxiety and depression among children and young peopleReview
      39. Exercise therapy for chronic fatigue syndromeReview
      40. Family interventions for bipolar disorderReview
      41. Family therapy for anorexia nervosaReview
      42. Family therapy for depressionReview
      43. Fluoxetine versus other types of pharmacotherapy for depressionReview
      44. Fluvoxamine versus other anti-depressive agents for depressionReview
      45. Folate for depressive disordersReview
      46. Haloperidol alone or in combination for acute maniaReview
      47. Hydroxyzine for generalised anxiety disorderReview
      48. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosaReview
      49. Inositol for depressive disordersReview
      50. Interventions for helping people recognise early signs of recurrence in bipolar disorderReview
      51. Interventions for pathological gamblingReviewWithdrawn
      52. Interventions for preventing eating disorders in children and adolescentsReview
      53. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsReviewComment
      54. Interventions for vaginismusReview
      55. Interventions to facilitate return to work in adults with adjustment disordersReview
      56. Interventions to improve occupational health in depressed peopleReview
      57. Kava extract versus placebo for treating anxietyReview
      58. Light therapy for non-seasonal depressionReview
      59. Lithium for maintenance treatment of mood disordersReview
      60. Lithium versus antidepressants in the long-term treatment of unipolar affective disorderReview
      61. Low dosage tricyclic antidepressants for depressionReview
      62. Marital therapy for depressionReview
      63. Meditation therapy for anxiety disordersReview
      64. Melatonin for the prevention and treatment of jet lagReview
      65. Milnacipran versus other antidepressive agents for depressionReview
      66. Mirtazapine versus other antidepressive agents for depressionReview
      67. Multiple session early psychological interventions for the prevention of post-traumatic stress disorderReview
      68. Music therapy for depressionReview
      69. Newer generation antidepressants for depressive disorders in children and adolescentsReview
      70. Olanzapine alone or in combination for acute maniaReview
      71. Olanzapine in long-term treatment for bipolar disorderReview
      72. Omega-3 fatty acids for bipolar disorderReview
      73. Oxcarbazepine for acute affective episodes in bipolar disorderReview
      74. Oxcarbazepine in the maintenance treatment of bipolar disorderReview
      75. Paraprofessionals for anxiety and depressive disordersReview
      76. Passiflora for anxiety disorderReview
      77. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseReview
      78. Pharmacological treatment for psychotic depressionReview
      79. Pharmacotherapy and psychotherapy for body dysmorphic disorderReview
      80. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disordersReview
      81. Pharmacotherapy for anxiety disorders in children and adolescentsReview
      82. Pharmacotherapy for dysthymiaReview
      83. Pharmacotherapy for post traumatic stress disorder (PTSD)Review
      84. Pharmacotherapy for social anxiety disorderReview
      85. Preventing occupational stress in healthcare workersReview
      86. Psychological and educational interventions for preventing depression in children and adolescentsReview
      87. Psychological debriefing for preventing post traumatic stress disorder (PTSD)Review
      88. Psychological therapies for generalised anxiety disorderReview
      89. Psychological therapies for pathological and problem gamblingReview
      90. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescentsReview
      91. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsReview
      92. Psychological treatment of post-traumatic stress disorder (PTSD)Review
      93. Psychological treatments for bulimia nervosa and bingingReview
      94. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD)Review
      95. Psychosocial and pharmacological treatments for deliberate self harmReview
      96. Psychosocial and psychological interventions for treating postpartum depressionReview
      97. Psychosocial interventions by general practitionersReview
      98. Psychosocial interventions for conversion disorderReview
      99. Psychosocial interventions for prevention of psychological disorders in law enforcement officersReview
      100. Psychostimulants for depressionReview
      101. Psychotherapeutic treatments for older depressed peopleReview
      102. Psychotherapies for hypochondriasisReview
      103. Relaxation for depressionReview
      104. Risperidone alone or in combination for acute maniaReview
      105. Risperidone in long-term treatment for bipolar disorderReview
      106. Screening and case finding instruments for depressionReview
      107. Second-generation antidepressants for seasonal affective disorderReview
      108. Second-generation antipsychotics for anxiety disordersReview
      109. Second-generation antipsychotics for major depressive disorder and dysthymiaReview
      110. Second-generation antipsychotics for obsessive compulsive disorderReview
      111. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)Review
      112. Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depressionReviewWithdrawn
      113. Self-help and guided self-help for eating disordersReview
      114. Sertraline versus other antidepressive agents for depressionReview
      115. Short-term psychodynamic psychotherapies for common mental disordersReview
      116. Sports and games for post-traumatic stress disorder (PTSD)Review
      117. St John's wort for major depressionReview
      118. Strategies for managing sexual dysfunction induced by antidepressant medicationReview
      119. Therapeutic touch for anxiety disordersReview
      120. Tiagabine for acute affective episodes in bipolar disorderReview
      121. Tiagabine in the maintenance treatment of bipolar disorderReview
      122. Topiramate for acute affective episodes in bipolar disorderReview
      123. Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndromeReview
      124. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorderReview
      125. Transcranial magnetic stimulation for treating depressionReview
      126. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)ReviewWithdrawn
      127. Tricyclic drugs for depression in children and adolescentsReview
      128. Tryptophan and 5-Hydroxytryptophan for depressionReview
      129. Valerian for anxiety disordersReview
      130. Valproate for acute mood episodes in bipolar disorderReview
      131. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorderReview
    3. Protocols
      1. Adjunctive antioxidants for bipolar disorderProtocol
      2. Agomelatine versus other antidepressive agents for major depressionProtocol
      3. Antipsychotic drugs for anorexia nervosaProtocol
      4. Aripiprazole alone or in combination for acute maniaProtocol
      5. Augmentation of psychotherapy with d-cycloserine for anxiety disordersProtocol
      6. Behavioural therapies versus other psychological therapies for depressionProtocol
      7. Behavioural therapies versus treatment as usual for depressionProtocol
      8. Benzodiazepines and related drugs for older depressed peopleProtocol
      9. Benzodiazepines for generalised anxiety disorder (GAD)Protocol
      10. Bibliotherapy for sexual dysfunctionProtocol
      11. Chinese herbs for insomniaProtocol
      12. Cognitive behavioural therapies versus other psychological therapies for depressionProtocol
      13. Cognitive behavioural therapies versus treatment as usual for depressionProtocol
      14. Cognitive behavioural therapy for anxiety disorders in later lifeProtocol
      15. Cognitive behavioural therapy for insomniaProtocol
      16. Dance movement therapy for depressionProtocol
      17. Debriefing for the prevention of psychological trauma in women following childbirthProtocol
      18. Electroconvulsive therapy for depressionProtocol
      19. Enhanced care by generalists for functional somatic symptoms and disorders in primary careProtocol
      20. Exercise for older depressed peopleProtocol
      21. Humanistic therapies versus other psychological therapies for depressionProtocol
      22. Humanistic therapies versus treatment as usual for depressionProtocol
      23. Interpersonal, cognitive analytic and other integrative therapies versus other psychological therapies for depressionProtocol
      24. Interpersonal, cognitive analytic and other integrative therapies versus treatment as usual for depressionProtocol
      25. Interventions for helping people recognise early signs of recurrence in depressionProtocol
      26. Interventions for mood and anxiety disorders, and self harm in young offendersProtocol
      27. Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adultsProtocol
      28. Mindfulness-based 'third wave' cognitive and behavioural therapies versus other psychological therapies for depressionProtocol
      29. Mindfulness-based 'third wave' cognitive and behavioural therapies versus treatment as usual for depressionProtocol
      30. Morita therapy for anxiety disordersProtocol
      31. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disordersProtocol
      32. Newer anticonvulsants in the treatment of anxiety disordersProtocol
      33. Paroxetine versus other anti-depressive agents for depressionProtocol
      34. Pharmacological interventions for the treatment of pathological and problem gamblingProtocol
      35. Pharmacological treatments for chronic fatigue syndrome in adultsProtocol
      36. Pharmacotherapy for anxiety disorders and comorbid alcohol dependencyProtocol
      37. Pharmacotherapy for bipolar disorder in older peopleProtocolNew
      38. Pharmacotherapy for prevention of post-traumatic stress disorderProtocol
      39. Pharmacotherapy for trichotillomaniaProtocol
      40. Prevention of suicide and suicidal behaviour in adolescentsProtocol
      41. Problem solving treatment (PST) for emotional problems in primary careProtocol
      42. Psychodynamic therapies versus other psychological therapies for depressionProtocol
      43. Psychodynamic therapies versus treatment as usual for depressionProtocol
      44. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorderProtocol
      45. Psychological, social and welfare interventions for psychological health and well-being of torture survivorsProtocol
      46. Psychological therapies versus pharmacotherapy for obsessive compulsive disorderProtocol
      47. Psychosocial interventions for prevention of depression in older peopleProtocol
      48. Psychotherapy for depression in children and adolescentsProtocol
      49. Reboxetine versus other antidepressive agents for depressionProtocol
      50. Reiki treatment for psychological symptomsProtocol
      51. Repetitive transcranial magnetic stimulation (rTMS) for panic disorderProtocol
      52. Therapist-delivered distance cognitive behavioural therapy for anxiety disorders in adultsProtocol
      53. Transcranial magnetic stimulation for post-traumatic stress disorderProtocol
      54. Venlafaxine versus other anti-depressive agents for depressionProtocol
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH